FREE SHIPPING ON ORDERS OVER $150

glutathione pancreatic cancer Reduced GCLC expression and de novo synthesis in Metabolic alterations in pancreatic cancers

$21.14

Quantity
- +
Description

Preclinical research utilizes BPC-157 to examine peptide-mediated cellular communication, extracellular matrix dynamics, and regulatory signaling under controlled laboratory conditions

glutathione pancreatic cancer Reduced GCLC expression and de novo synthesis in Metabolic alterations in pancreatic cancers

doi: 10.1016/j.biopsych.2021.02.968

glutathione pancreatic cancer Reduced GCLC expression and de novo synthesis in Metabolic alterations in pancreatic cancers

Each component is utilised in controlled research environments: BPC-157 (10mg): A synthetic peptide fragment associated with gastric-derived proteins, used in studies involving peptide structure, signalling pathways, and experimental biological systems

glutathione pancreatic cancer Reduced GCLC expression and de novo synthesis in Metabolic alterations in pancreatic cancers

for gastrointestinal health: Current and future perspectives

glutathione pancreatic cancer Reduced GCLC expression and de novo synthesis in Metabolic alterations in pancreatic cancers

You may also like

GHK-Cu

US$ 24.62

4.0 (19 reviews)

recommand products

QK041

US$ 21.53

Min. order: 1 piece

5.0 (6 reviews)

Sold : Login>>